First scan, then treat: 10 years of the SCOT-HEART study

Francesco Prati1,2, Andrea Giovagnoli1, Giulia Paoletti1

  • 1CLI Foundation, Rome, Italy.

Insights

Coronary CT imaging helps assess cardiovascular risk and atherosclerosis, guiding personalized medical therapy. Future advancements like photon-counting CT and AI may further enhance its clinical impact.

Area of Science:

  • Cardiovascular imaging
  • Radiology
  • Preventive cardiology

Background:

  • Coronary computed tomography (CT) use is increasing for assessing coronary artery disease and cardiovascular risk.
  • There is growing criticism of traditional ischemia-centered approaches to angina management.
  • The SCOT-HEART studies pioneered the use of coronary CT in angina patients.

Purpose of the Study:

  • To evaluate the impact of coronary CT on clinical outcomes in patients presenting with angina.
  • To assess the role of coronary CT in guiding medical therapy, particularly lipid-lowering treatments.
  • To explore the potential of emerging CT technologies and AI in cardiovascular imaging.

Main Methods:

  • Large randomized trials, such as SCOT-HEART, were conducted.
  • Coronary CT was used to identify atherosclerosis and guide treatment decisions.
  • Clinical outcomes were monitored following the adoption of coronary CT findings.

Main Results:

  • Coronary CT information led to improved clinical outcomes.
  • More aggressive medical therapy, including selective lipid-lowering treatment, was adopted based on CT findings.
  • Evidence of atherosclerosis guided targeted treatment strategies.

Conclusions:

  • Coronary CT is effective in improving outcomes for angina patients by enabling personalized risk assessment and treatment.
  • The integration of advanced technologies like photon-counting CT and AI holds promise for future advancements in cardiovascular CT imaging.
  • Further research, including primary prevention trials like SCOT-HEART 2, is anticipated to further shape clinical practice.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...